153 related articles for article (PubMed ID: 25885531)
1. Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program.
Stock D; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
Implement Sci; 2015 Mar; 10():35. PubMed ID: 25885531
[TBL] [Abstract][Full Text] [Related]
2. A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive result on a fecal occult blood test in Ontario's ColonCancerCheck program.
Stock D; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
Curr Oncol; 2017 Feb; 24(1):47-51. PubMed ID: 28270725
[TBL] [Abstract][Full Text] [Related]
3. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
4. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.
Correia A; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
Prev Med; 2015 Jul; 76():115-22. PubMed ID: 25895843
[TBL] [Abstract][Full Text] [Related]
5. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
[TBL] [Abstract][Full Text] [Related]
6. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests.
Van Kleek E; Liu S; Conn LM; Hoadley A; Ho SB
J Healthc Qual; 2010; 32(6):62-9. PubMed ID: 20946427
[TBL] [Abstract][Full Text] [Related]
7. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
8. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
10. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.
Lisi D; Hassan C; Crespi M;
Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888
[TBL] [Abstract][Full Text] [Related]
11. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
13. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
[TBL] [Abstract][Full Text] [Related]
14. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
15. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
McGregor S; Hilsden R; Yang H
Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
[TBL] [Abstract][Full Text] [Related]
16. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians.
Charters TJ; Strumpf EC; Sewitch MJ
BMC Health Serv Res; 2013 Oct; 13():449. PubMed ID: 24168208
[TBL] [Abstract][Full Text] [Related]
19. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.
Paszat L; Rabeneck L; Kiefer L; Mai V; Ritvo P; Sullivan T
Can J Gastroenterol; 2007 Jun; 21(6):379-82. PubMed ID: 17571172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
